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Abstract 
Septic shock remains a major cause of mor-
bidity  and  mortality  among  children,  mainly
due to acute hemodynamic compromise and
multiple  organ  failures.  In  the  last  decade,
international guidelines for the management
of  septic  shock,  as  well  as  clinical  practice
parameters for hemodynamic support of pedi-
atric  patients,  have  been  published.  Early
recognition and aggressive therapy of septic
shock, by means of abundant fluid resuscita-
tion, use of catecholamines and other adjuvant
drugs, are widely considered of pivotal impor-
tance to improve the short and long-term out-
come of these patients. The aim of this paper
is to summarize the modern approach to septic
shock in children, particularly in its very initial
phase,  when  pediatric  healthcare  providers
may be required to intervene in the pre-inten-
sive care unit setting or just on admission in
the pediatric intensive care unit.
Introduction
Severe sepsis and septic shock constitute a
relevant cause of morbidity and mortality in
critically ill children.1-3 Actually, most deaths
from sepsis occur globally in locations without
intensive care units, and many of them could
be prevented using relatively simple measures
as  recommended  by  the  World  Health
Organization-Integrated  Management  of
Childhood  Illnesses  guidelines.4 On  this
regard,  The  World  Federation  of  Pediatric
Intensive  Care  and  Critical  Care  Societies
(WFPICCS) has recently launched an impor-
tant quality improvement program (The Global
Pediatric  Sepsis  Initiative  at  http://www.
wfpiccs.org/sepsis  and  http://www.  pediatric-
sepsis.org), with the goal of ameliorating the
outcome of septic children worldwide, regard-
less the amount of available resources.5
Nonetheless, septic shock still represent a
clinical challenge even in developed countries,
being a leading causes of admissions to the
paediatric  emergency  department  and  the
pediatric intensive care unit.
In the last decades, several consensus con-
ferences about the criteria for defining sepsis
and  related  conditions  have  been  held.6
However, definitions of sepsis, severe sepsis,
septic  shock  and  multiple  organ
dysfunction/failure syndromes in children are
slightly different when compared to those used
for adults. In particular, septic shock in chil-
dren  is  defined  as  presence  of  sepsis  plus
signs of cardiovascular organ dysfunction,  not
necessarily  including  hypotension,  whilst  in
adult septic shock hypotension must be pres-
ent. (Table 1)6,7In addition, signs of organ dys-
function  depend  on  age-specific  heart  rate,
respiratory rate, and white blood cell count cut-
offs, which characteristically change in differ-
ent paediatric age groups. 
Guidelines  for  the  management  of  severe
sepsis  and  septic  shock,  sponsored  by  the
International Surviving Sepsis Campaign, and
clinical  practice  parameters  released  by  the
American  College  of  Critical  Care  Medicine
(ACCM)  for  hemodynamic  support  of  paedi-
atric and neonatal septic shock have been pub-
lished and recently updated.8-11
The aim of this paper is to summarize the
modern approach to septic shock in children in
its very initial phase, emphasising the pivotal
role of early recognition and prompt manage-
ment  of  this  life-threatening  condition,  in
PICU  but also in the pre-ICU setting. 
Pathophysiology of septic
shock
Shock  is  a  complex  clinical  syndrome
caused by an acute failure of circulatory func-
tion, with inadequate tissue and organ perfu-
sion, where delivery of oxygen and substrates
to body tissues, as well as removal of metabol-
ic waste products are inadequate. This results
in cellular dysfunction, which may eventually
lead to cell death. Shock is the common end-
point  of  many  pathophysiological  pathways.
There  are  three  major  categories  of  shock:
hypovolemic,  cardiogenic  and  distributive,
with a degree of overlap between these. Septic
shock usually fall into the categories of distrib-
utive and hypovolemic shock. In the distribu-
tive shock is prevalent a circulatory maldistrib-
ution  associated  with  peripheral  vasodilata-
tion, arterial and capillary shunting, whereas
in the hypovolemic shock there is inadequate
circulating  blood  volume,  despite  peripheral
vasoconstriction.
Hypotension  frequently  constitutes  one  of
the prominent features of shock, but could be a
late sign in pediatric patients.7,10,11
The most common causes of septic shock
are of bacterial origin, a classic example being
meningococcal disease. However, any organ-
ism can precipitate severe sepsis and septic
shock, including bacteria, viruses, mycobacte-
ria and fungi, especially in the immunocom-
promised host.
Early recognition of paediatric
septic shock
In the management of septic shock, early
diagnosis  and  prompt  treatment  have  the
greatest impact on clinical course and patient
outcome.  Indeed,  early  recognition  of  septic
shock and institution of antibiotic therapy can
reduce mortality in children.12,13 Furthermore,
early  institution  of  resuscitative  measures,
particularly by using aggressive fluid replace-
ment strategies, may prevent the child from
entering uncompensated or irreversible shock,
thereby reducing morbidity and mortality.
However, diagnosis of sepsis can be particu-
larly difficult in children, in whom a specific
signs  of  sepsis,  e.g. tachycardia,  tachypnoea
and fever, need a special interpretation due to
the variable range of normality depending on
the  patient  age.  Furthermore,  previously
healthy  children  with  intact  cardiovascular
homeostatic  mechanisms  can  compensate
extremely well during hypoperfusion states for
relatively long periods. Thus, shock in children
should be suspected by clinical and laboratory
signs, including altered mental status, tachyp-
noea and tachycardia, hypothermia or hyper-
thermia,  changes  in  peripheral  perfusion,
together with reduction of urine output, meta-
bolic  acidosis  and  increased  blood  lactate.
Importantly, hypotension is not necessary for
the  clinical  diagnosis  of  septic  shock,  even
though its presence in any child with clinical
suspicion of infection is confirmatory.7,11
In the emergency department setting, chil-
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dren  with  severe  infections  and  changes  in
peripheral perfusion are frequently described
as in warm shock or cold shock status, on the
basis of first clinical examination (Table 2).14
Early in the course of the disease process,
common observations usually include abnor-
mal  temperature  regulation,  flushed  warm
skin, a widened pulse pressure (warm shock),
tachycardia, tachypnoea, whereas mean arteri-
al pressure is frequently maintained. Clinical
signs of late septic shock include hypotension,
tachycardia with narrow pulse pressure, cold
extremities (cold shock), rapid shallow breath-
ing,  oliguria,  altered  level  of  consciousness,
and cyanosis due to pulmonary ventilation per-
fusion mismatch or underlying pulmonary dis-
eases. At present, international consensus rec-
ommends early recognition of pediatric septic
shock using simply clinical examination, not
biochemical tests, event though some experts
suggest to consider lactate levels as well.11
Early management of paedi-
atric septic shock: the golden
hour
Shock can rapidly evolve through different
phases,  usually  from  a  compensated  to  an
uncompensated status, which may ultimately
become  irreversible.  Aggressive  treatment
should be initiated in all cases where shock is
suspected. In fact, the mortality and outcome
of septic shock is likely influenced by the speed
and appropriateness of therapy administered
in the initial hours after the syndrome devel-
ops.12,15,16 The goal is to reverse shock and pre-
vent  multiple  organ  dysfunction.  To  achieve
this, the initial management of septic shock
(first hour) should focus on some major thera-
peutic  end  points  of  resuscitation,  which
include normalization of heart rate and blood
pressure (adjusted for age), capillary refill of
less than 2 seconds, normal pulses with no dif-
ferential between peripheral and central puls-
es, warm extremities, normal mental status,
urine output greater than 1 mL/kg/hr. In addi-
tion, normal glucose and ionized calcium con-
centrations  should  be  achieved  and  main-
tained.11
Once shock is suspected, appropriate sup-
portive measures must be instituted as soon as
possible,  ideally  following  the  ACCM  guide-
lines.11These include securing airway patency,
providing supplemental oxygen and positive-
pressure  ventilation,  achieving  vascular
access,  infusing  as  many  fluids  as  needed,
starting empiric antibiotic therapy, and provid-
ing support with inotropes and vasopressors,
as  clinically  indicated.  Importantly,  empiric
antibiotic  treatment  should  not  be  delayed
while waiting blood cultures to be sampled. 
Two levels of care can be then summarized:
first,  early  fluid  load,  mostly  for  outpatients
with community acquired infections; second,
advanced  technology  for  children  with
fluid/dopamine  refractory  illness,  scarcely
responding  to  the  initial  stabilization
attempts. These interventions can be located
at the onset and at the end of the golden hour,
according  to  international  guidelines,  where
time intervals for intensivists have been clear-
ly indicated.11 Indeed, the early interpretation
of hemodynamic pattern of septic shock can
guide  further  therapeutic  interventions  and
vasoactive  agents  introduction.  Thus,  early
referral to highly specialised centres, capable
to provide more sophisticated monitoring and
treatment, is strongly recommended. 
ABCs: airway and breathing
Airway,  breathing  and  circulation  remain
the  fundamental  principles  of  resuscitation
also in patients with septic shock. Priority is
given  to  the  airway,  which  is  immediately
assessed and secured, if necessary. High flow
oxygen via facemask or nasal canulae should
be given, even in the absence of respiratory
distress or hypoxemia. 
Aggressive airway management and  venti-
lation should be considered in any patient not
responding to fluid resuscitation and peripher-
ally administered inotropes. Indeed, early intu-
bation and mechanical ventilation may support
cardiac output (CO) by reducing the work of
breathing,  reduce  oxygen  consumption  by
sedation, facilitate procedures for establishing
invasive  hemodynamic  monitoring,  provide
airway protection.11
Vascular access
Rapid attainment of a vascular access is of
critical importance, possibly through the place-
ment  of  two  large  bore  peripheral  venous
catheters.  If  these  catheters  cannot  be
obtained  easily,  the  intraosseous  route  or  a
central venous catheter should be considered,
depending upon the available expertise. 
If at all possible, blood samples should be
taken for haematological parameters, urea and
electrolytes, blood glucose, culture and cross-
match. At this point empirical antibiotic thera-
py should be started intravenously. 
Fluid resuscitation
Rapid fluid boluses of 20 mL/kg should be
administered  (possibly  over  five  minutes),
observing for the development of lung rales or
hepatomegaly. Up to 60 mL/kg may be neces-
sary  in  the  first  hour;  however,  in  some
patients aliquots exceeding 150-200 ml/kg may
be required in the first hour. Fluid should be
pushed manually or by a pressure bag, with a
goal of attaining normal perfusion and blood
pressure.11 Use  of  both  crystalloid  or  colloid
solutions is generally considered appropriate.
In special cases, e.g.  when the source of hypo-
volemia  is  hemorrhage,  transfusion  with
packed red blood cells could be also considered,
particularly with haemoglobin  values below 10
ng/dL. 
However, there is little evidence about the
best type of resuscitation fluid, the appropriate
timing, volume, and rate of fluid administra-
tion.17 In particular, no clear advantages have
been demonstrated by using cristalloids rather
than  colloids  in  septic  shock  patients.18
Interestingly,  recent  findings  challenge  the
importance of bolus resuscitation as a lifesav-
ing intervention in resource-limited settings
for  children  with  shock  who  do  not  have
hypotension,  raising  questions  regarding
fluid-resuscitation guidelines in other settings
as well.19 Further research is clearly needed to
clarify such a controversial issue. 
Inotropic support
Children  with  septic  shock  uniformly
require  some  vasoactive  support  during  and
after  fluid  resuscitation.  Importantly,  in
patients not responsive to fluid resuscitation,
inotropic support should be started via a sec-
Review
Table 1. Cardiovascular dysfunction criteria (modified from Goldstein et al.7).
Despite administration of isotonic intravenous fluid bolus > 40 mL/kg in 1 hr: 
Decrease in blood pressure Need for vasoactive drug  Two of the following:
(hypotension) < 5th percentile  to maintain blood pressure 1) unexplained metabolic 
for age or systolic BP < 2 SD  in normal range (dopamine acidosis: base deficit > 5.0 mEq/L
below normal for age >5 mcg/kg/min or dobutamine,  2) Increased arterial lactate > 2
adrenaline, or noradrenaline  times upper limit of normal
at any dose) 3) Oliguria: urine output <0.5 mL/kg/hr
4) Prolonged capillary refill: > 5 secs
5) Core to peripheral temperature gap >3°C
Table 2. Clinical characteristics of cold and
warm shock(modified from Saladino et al. 14).
Cold shock Warm shock
Capillary  > 2 seconds Flash capillary refill
refill 
Peripheral  Diminished Bounding
pulses
Mottling  Present Absent
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ond  peripheral  access,  until  a  safer  central
venous access is obtained. 
Dopamine can be used and titrated as the
first-line agent, up to 10 mcg/kg/min. However,
if the patient is not rapidly responsive to ther-
apy, then adrenaline or noradrenaline should
be infused to restore normal blood pressure
and perfusion.9,11 In general, adrenaline rang-
ing from 0.05 to 0.3 mcg/kg/min should be used
in patients with normal or low blood pressure
and cold shock, whilst noradrenaline should be
titrated in patients with low blood pressure and
warm shock. 
Corticosteroids
Some patients with septic shock may suffer
of  severe  adrenal  insufficiency,  which  could
partially explain a scarce response to fluid and
catecholamine therapy. Risk factors for such
condition  include  purpura  fulminans,  prior
corticosteroid  use  and  pituitary  or  adrenal
abnormalities. In patients with fluid refractory,
catecholamine resistant shock, intermittent or
continuous infusions of hydrocortisone, rang-
ing from 1 up to 50 mg/kg/day is recommended
within 60 min of diagnosis of shock.9,11
Other therapies for acute manage-
ment of septic shock
Beyond the first hour of treatment, several
adjuvant therapies, including vasopressin, ter-
lipressin, levosimendan, milrinone, immuno  -
globulins,  and  protein  C  concentrate,  have
been attempted in pediatric septic shock, even
though evidence to support their use are still
lacking.9,11,20-24
Finally, children with septic shock scarcely
responding  to  initial  aggressive  treatments
must be suspected to have unrecognized mor-
bidities, including pericardial effusion, pneu-
mothorax, ongoing blood loss, hypoadrenalism,
hypothyroidism, inborn errors of metabolism,
or congenital heart disease. When these caus-
es have been excluded, extreme therapeutic
options such as extracorporeal membrane oxy-
genation (ECMO) should be considered.9-11
Advanced non invasive hemodynamic
monitoring
The invasive monitoring of cardiac output is
not  common  practice  in  the  pediatric  emer-
gency department. Interestingly, newer, nonin-
vasive, ultrasound techniques offer the oppor-
tunity to monitor the hemodynamic patterns of
children with septic shock, at a much earlier
stage  than  that  usually  accomplished  in  the
intensive care unit.
In a recent study, the hemodynamic patterns
of children with suspected fluid-resistant sep-
tic shock was investigated by means of a non-
invasive cardiac output device. Patients who
presented with central venous catheter-related
sepsis predominantly demonstrated a pattern
of  elevated  cardiac  index  with  low  systemic
vascular  resistance  (warm  shock),  whereas
those who presented with community acquired
sepsis predominantly exhibited a low or nor-
mal cardiac index, with normal or high sys-
temic vascular resistance (cold shock).25
Theoretically,  such  devices  may  provide  a
more specific assessment of the hemodynamic
status  of  these  patients,  even  in  the  emer-
gency  department  or  during  transportation,
helping the clinician to individualize the ther-
apeutic management.
Transfer of patients with septic
shock to a referral centre
Even when initial stabilisation has been cor-
rectly achieved, the early referral to a high-
level PICU may be life-saving for a child with
evolving septic shock. Indeed, more advanced
monitoring and treatment are best offered in
an  experienced  PICU  setting.  Areas  lacking
specialised paediatric ICUs should arrange for
a transfer system towards a tertiary PICU, ide-
ally by means of a specialised transport team.
Conclusions
Septic shock in children still constitutes a
clinical  challenge  for  healthcare  providers,
both  in  the  emergency  department  and  the
intensive care unit. Early diagnosis, allowing
rapid therapeutic intervention, is essential in
improving  the  outcome  of  these  patients.
Guidelines for the management of septic shock
have been published and are regularly updated
by  highly  recognized  international  bodies.
Current treatment includes early fluid resusci-
tation, tailored use of inotropes and vasopres-
sors, and use of adjuvant treatments, such as
hydrocortisone. Novel promising therapies are
on the horizon, but hitherto they remain large-
ly unproven in terms of efficacy and safety. 
Even  though  remarkable  advances  have
been made in the management of paediatric
septic shock, further research is still needed in
order to improve the short and long-term out-
come of these high-risk patients. 
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